Skip to main content

The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation

Publication ,  Conference
Sander, SD; Williams, CJ; Ciarametaro, M; Hahn, B; Chalissery, G; Reynolds, MW; Samsa, GP; Matchar, DB
Published in: STROKE
April 1, 2010

Duke Scholars

Published In

STROKE

ISSN

0039-2499

Publication Date

April 1, 2010

Volume

41

Issue

4

Start / End Page

E253 / E253

Location

San Antonio, TX

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

International Stroke Conference

Related Subject Headings

  • Neurology & Neurosurgery
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sander, S. D., Williams, C. J., Ciarametaro, M., Hahn, B., Chalissery, G., Reynolds, M. W., … Matchar, D. B. (2010). The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation. In STROKE (Vol. 41, pp. E253–E253). San Antonio, TX: LIPPINCOTT WILLIAMS & WILKINS.
Sander, Stephen D., Catherine J. Williams, Michael Ciarametaro, Beth Hahn, George Chalissery, Matthew W. Reynolds, Gregory P. Samsa, and David B. Matchar. “The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation.” In STROKE, 41:E253–E253. LIPPINCOTT WILLIAMS & WILKINS, 2010.
Sander SD, Williams CJ, Ciarametaro M, Hahn B, Chalissery G, Reynolds MW, et al. The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation. In: STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2010. p. E253–E253.
Sander, Stephen D., et al. “The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation.” STROKE, vol. 41, no. 4, LIPPINCOTT WILLIAMS & WILKINS, 2010, pp. E253–E253.
Sander SD, Williams CJ, Ciarametaro M, Hahn B, Chalissery G, Reynolds MW, Samsa GP, Matchar DB. The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation. STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2010. p. E253–E253.

Published In

STROKE

ISSN

0039-2499

Publication Date

April 1, 2010

Volume

41

Issue

4

Start / End Page

E253 / E253

Location

San Antonio, TX

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

International Stroke Conference

Related Subject Headings

  • Neurology & Neurosurgery
  • 4201 Allied health and rehabilitation science
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology